Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Rapid Emergence, Subsidence, and Molecular Detection of Escherichia coli Sequence Type 1193-fimH64, a New Disseminated Multidrug-Resistant Commensal and Extraintestinal Pathogen.

Johnson JR, Johnston BD, Porter SB, Clabots C, Bender TL, Thuras P, Trott DJ, Cobbold R, Mollinger J, Ferrieri P, Drawz S, Banerjee R.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e01664-18. doi: 10.1128/JCM.01664-18. Print 2019 May.

PMID:
30787145
2.

Extensive Genetic Commonality among Wildlife, Wastewater, Community, and Nosocomial Isolates of Escherichia coli Sequence Type 131 (H30R1 and H30Rx Subclones) That Carry blaCTX-M-27 or blaCTX-M-15.

Jamborova I, Johnston BD, Papousek I, Kachlikova K, Micenkova L, Clabots C, Skalova A, Chudejova K, Dolejska M, Literak I, Johnson JR.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e00519-18. doi: 10.1128/AAC.00519-18. Print 2018 Oct.

3.

Contribution of yersiniabactin to the virulence of an Escherichia coli sequence type 69 ("clonal group A") cystitis isolate in murine models of urinary tract infection and sepsis.

Johnson JR, Magistro G, Clabots C, Porter S, Manges A, Thuras P, Schubert S.

Microb Pathog. 2018 Jul;120:128-131. doi: 10.1016/j.micpath.2018.04.048. Epub 2018 Apr 24.

PMID:
29702209
4.

Virulence genes and subclone status as markers of experimental virulence in a murine sepsis model among Escherichia coli sequence type 131 clinical isolates from Spain.

Merino I, Porter SB, Johnston BD, Clabots C, Shaw E, Horcajada JP, Cantón R, Ruiz-Garbajosa P, Johnson JR; ITUBRAS-GEIH group.

PLoS One. 2017 Nov 30;12(11):e0188838. doi: 10.1371/journal.pone.0188838. eCollection 2017.

5.

Phylogenetic Backgrounds and Virulence-Associated Traits of Escherichia coli Isolates from Surface Waters and Diverse Animals in Minnesota and Wisconsin.

Johnson JR, Johnston BD, Delavari P, Thuras P, Clabots C, Sadowsky MJ.

Appl Environ Microbiol. 2017 Dec 1;83(24). pii: e01329-17. doi: 10.1128/AEM.01329-17. Print 2017 Dec 15.

6.

Epidemiology and characteristics of Escherichia coli sequence type 131 (ST131) from long-term care facility residents colonized intestinally with fluoroquinolone-resistant Escherichia coli.

Han JH, Garrigan C, Johnston B, Nachamkin I, Clabots C, Bilker WB, Santana E, Tolomeo P, Maslow J, Myers J, Carson L, Lautenbach E, Johnson JR; CDC Prevention Epicenters Program.

Diagn Microbiol Infect Dis. 2017 Mar;87(3):275-280. doi: 10.1016/j.diagmicrobio.2016.11.016. Epub 2016 Nov 28.

7.

Household Clustering of Escherichia coli Sequence Type 131 Clinical and Fecal Isolates According to Whole Genome Sequence Analysis.

Johnson JR, Davis G, Clabots C, Johnston BD, Porter S, DebRoy C, Pomputius W, Ender PT, Cooperstock M, Slater BS, Banerjee R, Miller S, Kisiela D, Sokurenko EV, Aziz M, Price LB.

Open Forum Infect Dis. 2016 Jun 16;3(3):ofw129. eCollection 2016 Sep.

8.

Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans.

Mohamed M, Clabots C, Porter SB, Thuras P, Johnson JR.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):4638-45. doi: 10.1128/AAC.00383-16. Print 2016 Aug.

9.

Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.

Drawz SM, Porter S, Kuskowski MA, Johnston B, Clabots C, Kline S, Ferrieri P, Johnson JR.

Antimicrob Agents Chemother. 2015 Sep;59(9):5331-9. doi: 10.1128/AAC.00048-15. Epub 2015 Jun 22.

10.

Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli.

Burgess MJ, Johnson JR, Porter SB, Johnston B, Clabots C, Lahr BD, Uhl JR, Banerjee R.

Open Forum Infect Dis. 2015 Feb 17;2(1):ofv011. doi: 10.1093/ofid/ofv011. eCollection 2015 Jan.

11.

Extraintestinal Pathogenic and Antimicrobial-Resistant Escherichia coli Contamination of 56 Public Restrooms in the Greater Minneapolis-St. Paul Metropolitan Area.

Mohamed M, Owens K, Gajewski A, Clabots C, Johnston B, Thuras P, Kuskowski MA, Johnson JR.

Appl Environ Microbiol. 2015 Jul;81(13):4498-506. doi: 10.1128/AEM.00638-15. Epub 2015 Apr 24.

12.

Colonization with Escherichia coli Strains among Female Sex Partners of Men with Febrile Urinary Tract Infection.

Ulleryd P, Sandberg T, Scheutz F, Clabots C, Johnston BD, Thuras P, Johnson JR.

J Clin Microbiol. 2015 Jun;53(6):1947-50. doi: 10.1128/JCM.00579-15. Epub 2015 Apr 1.

13.

Extensive Household Outbreak of Urinary Tract Infection and Intestinal Colonization due to Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131.

Madigan T, Johnson JR, Clabots C, Johnston BD, Porter SB, Slater BS, Banerjee R.

Clin Infect Dis. 2015 Jul 1;61(1):e5-12. doi: 10.1093/cid/civ273. Epub 2015 Mar 31.

14.

Clinical and microbiological determinants of infection after transrectal prostate biopsy.

Liss MA, Johnson JR, Porter SB, Johnston B, Clabots C, Gillis K, Nseyo U, Holden M, Sakamoto K, Fierer J.

Clin Infect Dis. 2015 Apr 1;60(7):979-87. doi: 10.1093/cid/ciu1129. Epub 2014 Dec 16.

PMID:
25516194
15.

Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012.

Olesen B, Frimodt-Møller J, Leihof RF, Struve C, Johnston B, Hansen DS, Scheutz F, Krogfelt KA, Kuskowski MA, Clabots C, Johnson JR.

Antimicrob Agents Chemother. 2014 Nov;58(11):6886-95. doi: 10.1128/AAC.03679-14. Epub 2014 Sep 8.

16.

Clinical and molecular epidemiology of Escherichia coli sequence type 131 among hospitalized patients colonized intestinally with fluoroquinolone-resistant E. coli.

Han JH, Johnston B, Nachamkin I, Tolomeo P, Bilker WB, Mao X, Clabots C, Lautenbach E, Johnson JR; CDC Prevention Epicenters Program.

Antimicrob Agents Chemother. 2014 Nov;58(11):7003-6. doi: 10.1128/AAC.03256-14. Epub 2014 Sep 8.

17.

Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131.

Johnson JR, Clermont O, Johnston B, Clabots C, Tchesnokova V, Sokurenko E, Junka AF, Maczynska B, Denamur E.

J Clin Microbiol. 2014 May;52(5):1358-65. doi: 10.1128/JCM.03502-13. Epub 2014 Feb 5.

18.

The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.

Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Billig M, Chattopadhyay S, Stegger M, Andersen PS, Pearson T, Riddell K, Rogers P, Scholes D, Kahl B, Keim P, Sokurenko EV.

MBio. 2013 Dec 17;4(6):e00377-13. doi: 10.1128/mBio.00377-13.

19.

Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.

Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR; VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) Investigators.

Clin Infect Dis. 2013 Nov;57(9):1256-65. doi: 10.1093/cid/cit503. Epub 2013 Aug 6.

20.

OxyR contributes to the virulence of a Clonal Group A Escherichia coli strain (O17:K+:H18) in animal models of urinary tract infection, subcutaneous infection, and systemic sepsis.

Johnson JR, Russo TA, Drawz SM, Clabots C, Olson R, Kuskowski MA, Rosen H.

Microb Pathog. 2013 Nov;64:1-5. doi: 10.1016/j.micpath.2013.07.001. Epub 2013 Jul 12.

PMID:
23850958
21.

Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts.

Banerjee R, Johnston B, Lohse C, Porter SB, Clabots C, Johnson JR.

Infect Control Hosp Epidemiol. 2013 Apr;34(4):361-9. doi: 10.1086/669865. Epub 2013 Feb 13.

22.

Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.

Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, Billig M, Riddell K, Rogers P, Qin X, Butler-Wu S, Price LB, Aziz M, Nicolas-Chanoine MH, Debroy C, Robicsek A, Hansen G, Urban C, Platell J, Trott DJ, Zhanel G, Weissman SJ, Cookson BT, Fang FC, Limaye AP, Scholes D, Chattopadhyay S, Hooper DC, Sokurenko EV.

J Infect Dis. 2013 Mar 15;207(6):919-28. doi: 10.1093/infdis/jis933. Epub 2013 Jan 3.

23.

Post-prostate biopsy infection with Escherichia coli ST131 leading to epididymo-orchitis and meningitis caused by Gram-negative bacilli.

Assimacopoulos A, Johnston B, Clabots C, Johnson JR.

J Clin Microbiol. 2012 Dec;50(12):4157-9. doi: 10.1128/JCM.02026-12. Epub 2012 Sep 26.

24.

Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia.

Platell JL, Trott DJ, Johnson JR, Heisig P, Heisig A, Clabots CR, Johnston B, Cobbold RN.

Antimicrob Agents Chemother. 2012 Jul;56(7):3898-904. doi: 10.1128/AAC.06120-11. Epub 2012 Apr 23.

25.

Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009.

Johnson JR, Nicolas-Chanoine MH, DebRoy C, Castanheira M, Robicsek A, Hansen G, Weissman S, Urban C, Platell J, Trott D, Zhanel G, Clabots C, Johnston BD, Kuskowski MA; MASTER Investigators.

Emerg Infect Dis. 2012 Apr;18(4):598-607. doi: 10.3201/eid1804.111627.

26.

Fluoroquinolone-resistant extraintestinal Escherichia coli clinical isolates representing the O15:K52:H1 clonal group from humans and dogs in Australia.

Platell JL, Cobbold RN, Johnson JR, Clabots CR, Trott DJ.

Comp Immunol Microbiol Infect Dis. 2012 Jul;35(4):319-24. doi: 10.1016/j.cimid.2012.02.002. Epub 2012 Mar 3.

PMID:
22385907
27.

Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.

Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS 2nd, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA; AMERECUS Investigators.

Antimicrob Agents Chemother. 2012 May;56(5):2364-70. doi: 10.1128/AAC.05824-11. Epub 2012 Feb 21.

28.

Community-associated Escherichia coli harboring CTX-M β-lactamases from urine cultures from pediatric patients.

Woods KL, Johnson JR, Padkowsky S, Mariano N, Colon-Urban R, Hassanein M, Wehbeh W, Johnston BD, Clabots C, Zahid S, Urban C.

Antimicrob Agents Chemother. 2012 Apr;56(4):2209-10. doi: 10.1128/AAC.00003-12. Epub 2012 Jan 17. No abstract available.

29.

Rates of mutation and host transmission for an Escherichia coli clone over 3 years.

Reeves PR, Liu B, Zhou Z, Li D, Guo D, Ren Y, Clabots C, Lan R, Johnson JR, Wang L.

PLoS One. 2011;6(10):e26907. doi: 10.1371/journal.pone.0026907. Epub 2011 Oct 27.

30.

Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia.

Platell JL, Cobbold RN, Johnson JR, Heisig A, Heisig P, Clabots C, Kuskowski MA, Trott DJ.

Antimicrob Agents Chemother. 2011 Aug;55(8):3782-7. doi: 10.1128/AAC.00306-11. Epub 2011 Jun 6.

31.

Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.

Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M.

Clin Infect Dis. 2010 Aug 1;51(3):286-94. doi: 10.1086/653932.

PMID:
20572763
32.

Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection.

Johnson JR, Anderson JT, Clabots C, Johnston B, Cooperstock M.

Pediatr Infect Dis J. 2010 May;29(5):473-5. doi: 10.1097/INF.0b013e3181c89bd7.

PMID:
19952857
33.

Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients.

Johnson JR, Johnston B, Clabots C, Kuskowski MA, Pendyala S, Debroy C, Nowicki B, Rice J.

Antimicrob Agents Chemother. 2010 Jan;54(1):546-50. doi: 10.1128/AAC.01089-09. Epub 2009 Nov 16.

34.

Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital.

Belmares J, Johnson S, Parada JP, Olson MM, Clabots CR, Bettin KM, Peterson LR, Gerding DN.

Clin Infect Dis. 2009 Oct 15;49(8):1141-7. doi: 10.1086/605638.

PMID:
19780659
35.

Transmission of an extended-spectrum-beta-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and Emphysematous pyelonephritis.

Ender PT, Gajanana D, Johnston B, Clabots C, Tamarkin FJ, Johnson JR.

J Clin Microbiol. 2009 Nov;47(11):3780-2. doi: 10.1128/JCM.01361-09. Epub 2009 Sep 9.

36.

Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and Urovirulent E. coli strains among dogs and cats within a household.

Johnson JR, Miller S, Johnston B, Clabots C, Debroy C.

J Clin Microbiol. 2009 Nov;47(11):3721-5. doi: 10.1128/JCM.01581-09. Epub 2009 Aug 26.

37.

Virulence genotypes and phylogenetic background of fluoroquinolone-resistant and susceptible Escherichia coli urine isolates from dogs with urinary tract infection.

Johnson JR, Kuskowski MA, Owens K, Clabots C, Singer RS.

Vet Microbiol. 2009 Apr 14;136(1-2):108-14. doi: 10.1016/j.vetmic.2008.10.006. Epub 2008 Oct 15.

PMID:
19019576
38.

Multiple-host sharing, long-term persistence, and virulence of Escherichia coli clones from human and animal household members.

Johnson JR, Clabots C, Kuskowski MA.

J Clin Microbiol. 2008 Dec;46(12):4078-82. doi: 10.1128/JCM.00980-08. Epub 2008 Oct 22.

39.

Predictors of antimicrobial-resistant Escherichia coli in the feces of vegetarians and newly hospitalized adults in Minnesota and Wisconsin.

Sannes MR, Belongia EA, Kieke B, Smith K, Kieke A, Vandermause M, Bender J, Clabots C, Winokur P, Johnson JR.

J Infect Dis. 2008 Feb 1;197(3):430-4. doi: 10.1086/525530.

PMID:
18184093
40.

Escherichia coli colonization patterns among human household members and pets, with attention to acute urinary tract infection.

Johnson JR, Owens K, Gajewski A, Clabots C.

J Infect Dis. 2008 Jan 15;197(2):218-24. doi: 10.1086/524844.

PMID:
18179385
41.

Virulence genotypes and phylogenetic background of Escherichia coli serogroup O6 isolates from humans, dogs, and cats.

Johnson JR, Johnston B, Clabots CR, Kuskowski MA, Roberts E, DebRoy C.

J Clin Microbiol. 2008 Feb;46(2):417-22. Epub 2007 Nov 14.

42.

Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004.

Johnson JR, Sannes MR, Croy C, Johnston B, Clabots C, Kuskowski MA, Bender J, Smith KE, Winokur PL, Belongia EA.

Emerg Infect Dis. 2007 Jun;13(6):838-46.

43.

Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis.

Johnson JR, Clabots C.

Clin Infect Dis. 2006 Nov 15;43(10):e101-8. Epub 2006 Oct 10.

PMID:
17051483
44.
45.

Phylogenetic relationships among clonal groups of extraintestinal pathogenic Escherichia coli as assessed by multi-locus sequence analysis.

Johnson JR, Owens KL, Clabots CR, Weissman SJ, Cannon SB.

Microbes Infect. 2006 Jun;8(7):1702-13. Epub 2006 Apr 21.

PMID:
16820314
48.

The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection.

Johnson JR, Jelacic S, Schoening LM, Clabots C, Shaikh N, Mobley HL, Tarr PI.

Infect Immun. 2005 Feb;73(2):965-71.

50.

Molecular analysis of a hospital cafeteria-associated salmonellosis outbreak using modified repetitive element PCR fingerprinting.

Johnson JR, Clabots C, Azar M, Boxrud DJ, Besser JM, Thurn JR.

J Clin Microbiol. 2001 Oct;39(10):3452-60.

Supplemental Content

Loading ...
Support Center